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Summary Male C57BL/65 mice received a basal diet supplemented with 4% soya-bean oil, linseed oil or fish
oil, in which the major polyunsaturated fatty acids were linoleic acid, alpha-linolenic acid and long chain
omega-3 fatty acids, respectively. Groups of animals were injected into the right flank with EL4-lymphoma
cells, others with thymoma cells. Tumour implantation caused a gradual decrease in food consumption with
both types of tumour, while body weight increased, especially in the EL4-bearing animals receiving the
soya-bean diet. The weight gain was due to body water accumulation and was accompanied by decreases in
body fat and minor changes in carcass protein and ash contents. The dietary treatments did not produce
significant differences in tumour incidence and mortality, but tumour size was decreased by diets supplying
omega-3 fatty acids: in the EM mice tumour weight was markedly depressed by linseed oil, compared to
soya-bean oil, whereas thymoma tumour weight was lowest in mice receiving fish oil and highest in the
soya-bean oil group. Both types of tumour caused pronounced hypoglycaemia and hyperinsulinaemia in the
hosts, and the effect was modulated by the diets in the EL4 but not in the thymoma animals: the plasma
glucose level was especially low in the linseed oil group and relatively highest in the soya-bean oil treatment.
The degree of hyperinsulinaemia depended on the diet only in the thymoma-bearing mice, with linseed and fish
oils producing higher insulin levels than soya-bean oil. A slight hyperinsulinaemia was also observed in linseed
and fish oil-fed control mice. Serum triglycerides were elevated in tumour-bearing animals, without consistent
differences between dietary treatments. Although no clear pattern emerged concerning total cholesterol and
LDL levels, HDL values were strongly affected by the type of oil: in the control animals linseed oil caused an
increase in HDL-cholesterol compared to the other two oils. The thymoma-bearing mice responded to the
linseed and fish oil diets with greatly elevated HDL-cholesterol levels. The results point to important
differences in the responses of the two implanted tumours and hosts not only to the omega-6 and omega-3
fatty acids, but also to the type of dietary omega-3 fatty acids, namely alpha-linolenic acid and long chain fish
oil polyunsaturated fatty acids.
Omega-6 polyunsaturated fatty acids (PUFA) have been
reported to increase the incidence, growth and metastasis of
experimental tumours (Carroll & Hopkins, 1979; Carroll,
1980; Hubbard & Erickson, 1987; Roebuck et al., 1981). On
the other hand, recent studies using fish oils as a source of
omega-3 PUFA suggest that these fatty acids either have no
enhancing effect or cause inhibitory effects on some trans-
plantable or carcinogen-induced tumours (Braden & Carroll,
1986; Carroll & Braden, 1984; Jurkowski & Cave, 1984,
1985; Karmali et al., 1984; Karmali, 1987; O'Connor et al.,
1985; Reddy & Maruyama, 1986; Reddy & Sugie, 1988).
The mechanisms of action of these PUFA on host and
tumour are not fully established. Some reports suggest that
linoleic acid, the parent fatty acid of the omega-6 family,
potentiates tumorigenesis by providing structural and func-
tional essential fatty acids to dividing cells and by serving as
a precursor to oxygenated metabolites of arachidonic acid,
among which PGE2 in turn may be involved in tumour
development (Jurkowski & Cave, 1985; Hillyard & Abraham,
1979; Abraham & Hillyard, 1983; Carter et al., 1983). On the
other hand, the omega-3 parent compound, alpha-linolenic
acid, inhibits linoleic acid conversion to arachidonic acid,
and its long-chain derivative, eicosapentaenoic acid, interferes
with the conversion of arachidonic acid to prostaglandins
(Culp et al., 1979; Goodnight et al., 1982).
High-PUFA diets, mainly those containing omega-3
PUFA, depress serum cholesterol (Phillipson et al., 1985),
evoke hyperinsulinaemia (Lardinois, 1987; Lardinois et al.,
1987) and alleviate the alloxan-induced diabetic status in
mice (Yam, 1989). Hyperinsulinaemia is sometimes accom-
panied by hyperglycaemia or by postprandial glucose
intolerance (Lardinois et al., 1987; Hartog et al., 1987).
Whereas conflicting observations have been reported regard-
ing blood cholesterol and its possible role in cancer (De
Waard, 1975; Fernleib, 1983; McMichael et al., 1984), insulin
has been shown to influence the development of various
tumours by enhancing the growth of insulin-dependent
tumours (Pavelic & Slijepcevic, 1978) and by inhibiting the
insulin-sensitive ones (Cohen & Hilf, 1974, 1975; Feldman &
Hilf, 1985; Salter et al., 1958). Therefore it may be suggested
that the effect of dietary PUFA on tumours may also depend
to some extent on the tumour-insulin relationship.
The influence of tumours on the host's food intake and
body weight varies. Significant weight loss has been reported
in patients with the appearance of the first symptoms of
neoplasia (Robbins, 1974; Nathanson & Hall, 1974). MAC
16 colon adenocarcinoma-bearing mice showed a progressive
decrease in carcass weight as the tumour size increased
(Bibby et al., 1987; Beck & Tisdale, 1987), whereas an
opposite trend was observed in thymoma-bearing mice
(Pavelic & Slijepcevic, 1978). While no drop in caloric intake
was observed in the MAC 16 colon adenocarcinoma-bearing
mice, anorexia was consistently seen in methylcholanthrene-
induced sarcoma in Fisher rats (Moley et al., 1988) and in
some human cancers (Nathanson & Hall, 1974). It seems that
the weight loss of the host is associated with a decrease in
both fat and lean tissue (Beck & Tisdale, 1987; Moley et al.,
1988).
The purpose of the present study was to determine how
diets differing in the contents of various omega-6 and omega-
3 PUFA affect two transplantable tumours differing in their
dependence on insulin: EL4-lymphoma, assumed to be an
insulin-producing/secreting tumour (Yam et al., 1990), and
thymoma, an insulin-dependent tumour (Pavelic & Sli-
jepcevic, 1978).
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Materials and methods
Animals, diets and management
C57BL/6J male mice (26-30 weeks old) were purchased from
Jackson Laboratories (Pearl Harbor, Maine, USA). They
were kept in filter-covered plastic cages (ten mice per cage)
and fed ad lib. with a basal pelleted diet (Table 1) supple-
mented with 35 g kg-' soya-bean oil until the start of the
experiment. The basal diet contained (%): protein 21.1, ether
extract 2.66, and crude fibre 4.15.
Table I Composition of the basal diet without added oils
Ingredients gkg-'
Maize 587
Defatted soya-bean meal (48% protein) 320
Wheat bran 40
DL-methionine 4
L-lysine 5
Limestone 10
Dicalcium phosphate 9
NaCl 5
Vitamins-microelements mixa 20
aTo supply per kg of diet: vit. A, 26,000 IU; vit. D3, 4,000 IU;
DL-x-tocopheryl acetate, 224 mg; vit. K, 90 mg; thiamine HCI,
65 mg; riboflavin, 30mg; niacine, 65 mg; pantothenic acid, 245 mg;
pyridoxine, 20 mg; folic acid, 10mg; B,2, 0.004 mg; choline chloride,
2 g; p-aminobenzoic acid, 50 mg; ethoxyquin, 124 mg; manganese,
65 mg; zinc, 100 mg; iron, 20mg; copper, 2 mg; iodine, 1.30mg;
cobalt, 0.8 mg; selenium, 0.1 mg.
Three groups of 130 mice each (13 cages per group, each
cage containing ten animals) were fed the basal diet supple-
mented with either 4% soya-bean oil (SBO), linseed oil
(LSO) or fish oil (FO) (mackerel, pilchard forrel oil, Sherer
A.G., Baden, FRG). The fatty acid composition of the ex-
perimental oils and of the lipids extracted from the basal diet
was determined by gas-liquid chromatography and the fatty-
acid contents of the experimental diets are presented in Table
II. The oils were mixed with the basal diet daily before filling
the food cups and the food remaining from the previous day
was discarded.
Table II Fatty acid contents (%) and w6/w3 fatty acid ratios of the
experimental dietsa
Basal diet supplemented with
Fatty acid SBO LSO FO
16:0 0.79 0.70 1.19
16:1 0.04 0.04 0.61
18:0 0.22 0.27 0.20
18:1 1.61 1.13 1.11
18:2 w6 3.05 1.69 1.30
18:3 (3 0.26 2.15 0.02
20:1 b - 0.08
20:4 w6 - - 0.07
20:5w3 - - 0.89
22:5 w3 - _ 0.07
22:6 o3 - - 0.44
w6/w3 11.9 0.8 1.0
SBO, soya-bean oil; LSO, linseed oil; FO, fish oil. Shorthand
designations of fatty acids, no. of C atoms: no. of double bonds.
aBased on the fatty acid analysis of the basal diet and added oils.
bNot detectable.
After 8 days of supplementation of the diet with the
experimental oils, five cages (50 mice) from each dietary treatment were selected at random and the animals were
injected in the right flank muscle with 1.5 x 106 EL4-
lymphoma (EL4) cells. An additional 50 mice from each
dietary treatment were similarly inoculated with 0.2 x 106
thymoma tumour cells. The 30 remaining mice in each
dietary treatment were kept as intact controls (C).
Tumour cells EL4 cells (C57BL/6J lymphoma) were main-
tained by serial passage in the mice flanks. Thymoma cells
produced according to Haran-Ghera et al. (1977) were pro-
vided by A. Peled, Weizmann Institute of Science. Tumour
cell suspensions were washed three times by centrifugation
with phosphate buffered saline (Gibco Ltd, UK). EL4 and
thymoma cell viability was ascertained by trypan blue ex-
clusion and found to be approximately 80 and 90%, respec-
tively.
Body weight and food intake were recorded in all groups.
Thirty mice per dietary treatment were killed by decapitation
12 and 16 days after implantation of EL4 and thymoma cells,
respectively, and blood was collected immediately. The
presence of tumour in its early stage of development was
determined by palpation. The 30 control counterparts from
each dietary regimen were sacrificed together with the
thymoma group on day 16. Blood was collected immediately
and the carcass was kept frozen at - 20°C for further
chemical analyses. Mortality was determined on the remain-
ing 20 tumour bearing mice from each group.
Bloodanalyses
All analyses were carried out in triplicate on blood pooled
from ten mice per cage. Part of the blood was transferred to
precooled centrifuge tubes containing fluoride-oxalate and
centrifuged at 1,500 r.p.m. during 10 min. Plasma glucose
was determined the same day by the glucose oxidase proce-
dure according to Pennock et al. (1973).
After coagulation (2 h, 5°C) and centrifugation, the serum
was collected and frozen. The insulin level was determined in
the serum by a double antibody radioimmunoassay, using
'25N-labelled human insulin (Pharmacia Diagnostics AB, Upp-
sala, Sweden). Total cholesterol was determined in serum by
an enzymatic colourimetric method according to Siedel et al.
(1983) (Monotest Cholesterol, Bohringer Diagnostica,
GmbH, Mannheim, FRG). Triglycerides (TG) were deter-
mined by an enzymatic procedure according to Fossati and
Principe (1982) (Triglycerides Enzymatiques PAP 1000, Bio-
Merieux, Charbonnieres-les-Bains, France). High-density
lipoproteins (HDL) were analysed according to Lopes-Virella
et al. (1977) (CHOD-PAP-Methods, Bohringer Diagnostica,
GmbH, Mannheim, FRG). Low-density lipoprotein (LDL)
was calculated by difference:
LDL = Total cholesterol - (TG/5) - HDL
Body and tumour composition
Body composition was carried out on mouse carcasses stored
at - 20C after blood collection and removal of the tumour
or, in the case ofcontrol mice, the left flank. The tumour was
carefully freed of adhering muscle and weighed. The com-
position of the left flank was determined in intact mice. The
carcass, flank or tumour were dried in vacuo at 60°C to
constant weight (about 24 h) and water content was cal-
culated by difference. Total fat was determined by ethyl ether
extraction of the desiccated material with a Soxhlet
apparatus. After ash determination, protein was calculated
by difference:
Protein = tissue weight - (water + ash + ether extact)
Body composition was determined for individual mice
(10-12 mice per type of tumour and dietary regime), while
tumour and tibia muscle composition was determined in
triplicate on the pooled samples from each dietary treatment
and for each type of tumour.
Statistical analysis
Blood components were analysed by two-way analysis of
variance, body and tumour weight and composition by one-
way analysis of variance. Differences between dietary treat-
ment means were assessed by Duncan's multiple range test
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Results
Tumour incidence andmortality
Tumours were detected in EL4-bearing mice 7 days after
tumour transplantation; the following day the incidence rose
to about 80%. In the thymoma groups tumours appeared
later, 15 days after transplantation, the incidence reaching
85% on day 19 after transplantation. Tumour incidence was
not affected by the source of dietary oil.
Mortality closely followed the increase in tumour
incidence. In the EL4 mice the first deaths occurred on day
13 after transplantation, and on day 16 most of the mice had
died. In the thymoma group, mortality started on day 19
after transplantation and reached about 80% on day 25.
Mortality was not affected by the source of dietary oil.
Food intake and body weight (Figure 1)
Food intake decreased gradually in implanted mice, more
rapidly in the thymoma than in the EL4-bearing mice. The
source ofdietary oil had a slight but consistent effect on food
intake in the tumour-bearing mice, with the lowest values
obtained with FO, the highest with SBO.
In the EL4 mice, tumour transplantation was followed by
a marked increase in body weight (Figure 1) which was more
pronounced in the mice fed SBO than in those fed LSO or
FO. Thymoma implanted mice tended to lose weight, except
the SBO group in which a moderate increase was seen.
Carcass content ofwater, protein,fat and ash (Table III)
The increase in body weight ofthe EL4-bearing mice was due
mainly to water accumulation, which was greater in the SBO
group than in the other dietary treatments. Such an effect
was not observed in the thymoma-bearing mice.
Protein and ash contents were less in the tumour-bearing
mice than in the controls when the animals received LSO or
FO, but such a tumour effect was not seen in the SBO-fed
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Table III Carcass composition of mice at autopsy (g per carcass)
Main effects
SBO LSO FO s.e.m. T 0 TxO
Carcass water
Control 16.3a 17.2a 16.9a
EL4 28.la 21.7b 220b 0.94 ** * *
Thymoma 17.9a 16.5a 16.7a
Carcass fat
Control 1.74b 2.63a 2.42a
EMA 1.04a 0.93a 0.88a 0.15 ** * *
Thymoma 1.15a 0.47b 0.83ab
Carcass ash
Control 1.Olb 1.21a 1j09ab
EL4 1.1 la 0.91b 0.86b 0.04 * * *
Thymoma 1.03a 0.86a 0.98a
Carcass protein
Control 5.47a 5.70a 5.54a
ELM 6.25a 5.1lb 4.86b 0.21 n.s. * *
Thymoma 5.67a 5.21a 5.46a
Mean values from 10-12 mice for each type of tumour and dietary
treatment. s.e.m., pooled standard error of the means. Values within
rows with different superscripts differ to a statistically significant
degree , P <0.05 (e.g. there is no significant difference between values
carrying the superscripts ab and a). The main effects on carcass
composition are those caused by T (presence or absence oftumour), or
O (dietary oil, i.e. soya-bean oil SBO, linseed oil LSO, fish oil FO),
and the interaction between T and 0 (T x 0). n.s., non-significant;
*P<0.05; **P<0.01.
mice. The interaction between tumour and oil source may be
accounted for by the effect of the source of oil: feeding LSO
and FO was accompanied by an increase in body protein and
ash in the controls, while the tumour-bearing mice exhibited
a decrease in these components.
Body fat was increased in the control animals fed LSO or
FO but it was reduced dramatically as a result of tumour
development, especially in the LSO-supplemented thymoma
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Figure 1 Food intakes and body weights ofcontrol mice and ofmice bearing EMA or thymoma tumours (tumour weights included),
fed diets supplemented with soya-bean oil (0), linseed oil (A) or fish oil (A). Since no differences were obtained in food intake and
body weight in the control groups receiving different oils, the data obtained with the three dietary regimes were pooled and the mean
control values (0) are shown together with the ELM (left) and thymoma data (right). Vertical lines represent the standard error ofthe
mean. Statistical analysis ofthe data over the whole experimental period reveals the following effects: for food intake, both tumour (T)
and oil (0) effects are highly significant (P <0.01), while the T x 0 interaction is significant (P <0.05); for weight gain, the T effect
and the T x 0 interaction are significant (P <0.05).
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Table IV Tumour weightc and fat contentd of tumour and control
muscle at autopsy
Main effects
SBO LSO FO s.e.m.' T 0 TxO
Tumour weight (g)
EL4 3.09a 2.13b 2.67ab 0.11 * * *
Thymoma 2.21a 1.92ab 140b
Fat content (%)
Control 4.21a 4.17a 4.03a
EL4 tumour 2.13a 2.07a 2.31a 0.13 ** * *
Thymoma tumour 1.73a 0.78b 1.80a
Values within rows with different superscripts differ to a
statistically significant degree, P <0.05, (e.g. there is no significant
difference between values carrying the superscripts ab and a). cMean
values from 22-26 observations. dMean values for three pooled
samples from 6-7 mice each. es.e.m., pooled standard error of the
means. The main effects on tumour weight and fat content are those
caused by T (presence or absence of tumour), or 0 (dietary oil, i.e.
soya-bean oil SBO, linseed oil LSO, fish oil FO), and the interaction
between T and 0 (TxO). *P<0.05; **P<0.01.
Table V Blood plasma or serum composition
Main effects
SBO LSO FO s.e.m. T 0 TxO
Glucose (mg 100 ml-' plasma)
Control 141a 157a 154a
EL4 54a 1sc 37b 8.1 ** n.s. *
Thymoma 69a 42a 43a
Insulin (sUml-' serum)
Control 7.1b 11.4a 11.62
EMA 30.2a 32.4a 38.2 a 2.8 ** * *
Thymoma 26.4b 61.2a 53.2a
Triglycerides (mg 100 ml' serum)
Control 174a 184a 128a
EL4 261a 302a 278a 20 ** n.s. n.s.
Thymoma 232a 204a 208a
Total cholesterol (mg 100 ml-' serum)
Control 151a 131ab g1b
EL4 144ab 173a 120b 16 ** * n.s.
Thymoma 154a 185a 168a
HDL cholesterol (mg 100ml-' plasma)
Control 3.9b 10.6a 3.6b
EL4 14.7a 16.8a n.d. 3.3 ** * *
Thymoma 7.9b 55.8a 42.3a
LDL cholesterol (mg 100ml-' plasma)
Control 112.3a 83.6a 61.8a
EL4 77.1a 95.8a n.d. 11 n.s. n.s. n.s.
Thymoma 99.7a 88.4a 84.1a
Measurements were carried out on three pooled samples from ten
mice each for each type of tumour and dietary treatment. s.e.m.,
pooled standard error of the means. Values within rows with
different superscripts differ to a statistically significant degree,
P <0.05 (e.g. there is no significant difference between values
carrying the superscripts ab and a). The main effects on blood
plasma or serum composition are those caused by T (presence or
absence of tumour), or 0 (dietary oil, i.e. soya-bean oil SBO, linseed
oil LSO, fish oil FO), and interaction between T and 0 (T x 0). n.s.,
non-significant; n.d., not determined; *P<0.05; **P<0.01.
mice. The type of oil had no significant effect on body fat in
the EL4 mice.
Tumour weight and composition (Table IV)
Tumour weight was generally proportional to the increase in
host body weight but there were differences due to the diets.
In the EL4 mice receiving LSO tumour weight was smaller
than in the SBO group (P <0.05) and in the FO supple-
mented animals (non-significant). In the thymoma mice, the
tumour weight was lowest in the FO group and highest in the
SBO treatment (P <0.05). The tumours contained less fat
than the muscle excised from control mice, and fat concent-
ration was lower in thymoma than in EL4. While in the EL4
mice, tumour fat concentration was not affected by the
source of oil, in the thymoma mice, LSO depressed the
tumour fat concentration more than SBO or FO.
Blood components (Table V)
Glucose and insulin Glucose levels were much lower and
insulin levels much higher in the tumour-bearing mice than in
the controls. An interaction was obtained between the type
of oil and the tumour. While the source of oil had no
significant effect on glycaemia in the control mice, in the
tumour-bearing animals dietary supplementation with LSO
or FO was accompanied by a reduction of glucose, the effect
being especially dramatic for EL4 mice receiving LSO.
Thymoma mice responded to LSO and FO supplementation
by an over two-fold increase in serum insulin compared to
SO. A similar dietary effect was observed in the control mice
but not in the EL4 bearing animals.
Serum triglycerides and cholesterol The main overall effect
of tumour implantation was a highly significant increase in
both triglycerides and cholesterol. FO caused a drop in total
cholesterol in the controls and EL4 animals. The dietary oils
had no significant effects. No clear pattern emerged concern-
ing the relation between serum total cholesterol and the
dietary treatments, although the overall effect of the diets
was significant, with FO tending to produce the lowest values
in control and EL4 mice.
LDL and HDL Tumour implantation resulted in increased
HDL levels, especially in thymoma mice receiving LSO and
FO. HDL values of control mice were elevated significantly
by the LSO treatment. There were no significant differences
between LDL values due to tumour implantation or oil
treatments.
Discussion
Our results confirm the inhibitory action on tumour growth
of fish oil, as first reported by Karmali et al. (1984) and
Jurkowski and Cave (1984) for transplants of mammary
tumours in rats and confirmed since then by others for a
variety of experimental tumours (for a review see Karmali,
1987). However, in our study, while the long-chain omega-3
fatty acids from FO caused a significant reduction in the
weight of thymoma lymphoma, alpha-linolenic acid provided
by LSO was most effective as an inhibitor of EL4 growth.
The anti-tumour activity of alpha-linolenic acid, in con-
trast to the more widely studied effects of long-chain fatty
acids from fish oils, has been observed by others. For in-
stance, Fritsche and Johnston (1988) recently reported an
inhibitory effect of LSO on both growth and metastasis of a
tumour cell line with strong metastatic properties trans-
planted into mice, compared to corn oil and FO. Anti-
tumour effects of dietary alpha-linolenic acid were also
reported for different animal models by Hori et al. (1987)
and Cameron et al. (1989). Our results, and those of Hori et
al. (1987) lead to the conclusion that the antitumour poten-
tial of alpha-linolenic acid in different experimental models
may differ from that of the long-chain omega-3 fatty acids
from FO.
A factor causing considerable variability in the results is
the amount of test oil added to the basal diet. For instance,
menhaden oil at 20% in the diet reduced the growth and
incidence of DMBA-induced mammary tumours, compared
to 20% corn oil, but at 3% these oils yielded comparable
results (Braden & Carroll, 1986). Hopkins et al. (1981) found
that 3% menhaden oil actually stimulated tumour growth in
that same model. In the present study a relatively small
amount of 4% test oil was added to a basal diet already
containing 1% linoleic acid. It is therefore possible that the
supply of a larger amount of omega-3 fatty acids, or an
increased ratio of omega-3 to omega-6 fatty acids, wouldINSULIN-TUMOUR INTERRELATIONSHIPS 901
have caused more dramatic effects, especially in regard to
tumour incidence and survival rate which were not
significantly different in the dietary treatments for either of
the two tumour models.
Although no clearcut relation between blood cholesterol
and triglycerides and tumourigenesis was found, tumour-
bearing mice were hypertriglyceridaemic (Table V), which
may be the result of intense mobilisation and depletion of
carcass fat (Table III).
The pronounced hyperinsulinaemia seen in tumour-
implanted mice and especially in thymoma animals fed LSO
or FO is of interest. It may have been caused by a combina-
tion of several factors: (a) increased insulin levels caused by
the omega-3 fatty acids (Lardinois, 1987; Lardinois et al.,
1987), as also seen from the results obtained in the present
study; (b) insulin secretion by such insulin-producing
tumours as EL4 (Yam et al., 1990); and (c) enhanced secre-
tion of insulin by the P-cells of the host's pancreas, induced
by thymoma, presumably via some messenger (Pavelic &
Slijepcevic, 1978), a view that is also supported by results
obtained with alloxan-diabetic mice (Yam et al., 1990). High
blood insulin levels are generally accompanied by develop-
ment of insulin resistance in normal cells because of down-
regulation of insulin receptors, but this process is absent in
tumour cells (Mountjoy et al., 1983, 1987). Hyperinsulin-
aemia would therefore be expected to inhibit insulin-sensitive
tumours and confer advantages on insulin-dependent
tumours, such as thymoma, but in fact, tumour weight was
lowest in those dietary groups in which insulin levels were
highest. We believe that under conditions of hyperin-
sulinaemia, other factors become operative in limiting the
multiplication of cancer cells, possibly the availability of
arachidonic acid, an essential membrane lipid constituent, or
plasma glucose, an essential fuel for the energy metabolism
of tumour cells and whose depletion is also involved in
cachexic processes. In support of this view we find that,
among the dietary oils, it is LSO which has the strongest
hypoglycaemic effect in EL4 mice (Table V) while yielding
the smallest size of this tumour (Table IV). In addition, the
inhibitory action of omega-3 fatty acids on PGE2 production
by tumour cells, which has long been thought to be involved
in tumorigenesis by weakening the immune defence system of
the host, may counteract the stimulating effect of insulin.
We conclude that the insulinaemic and glycaemic status of
the host may modify the inhibitory effects of omega-3 fatty
acid-containing oils in some types of cancer.
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